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Abstract
Numerous cellular proteins interact with membrane surfaces to affect essential cellular processes. These interactions can be directed towards
a specific lipid component within a membrane, as in the case of phosphoinositides (PIPs), to ensure specific subcellular localization and/or
activation. PIPs and cellular PIP-binding domains have been studied extensively to better understand their role in cellular physiology. We applied
a pH modulation assay on supported lipid bilayers (SLBs) as a tool to study protein-PIP interactions. In these studies, pH sensitive ortho-
Sulforhodamine B conjugated phosphatidylethanolamine is used to detect protein-PIP interactions. Upon binding of a protein to a PIP-containing
membrane surface, the interfacial potential is modulated (i.e. change in local pH), shifting the protonation state of the probe. A case study of
the successful usage of the pH modulation assay is presented by using phospholipase C delta1 Pleckstrin Homology (PLC-δ1 PH) domain and
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) interaction as an example. The apparent dissociation constant (Kd,app) for this interaction was
0.39 ± 0.05 µM, similar to Kd,app values obtained by others. As previously observed, the PLC-δ1 PH domain is PI(4,5)P2 specific, shows weaker
binding towards phosphatidylinositol 4-phosphate, and no binding to pure phosphatidylcholine SLBs. The PIP-on-a-chip assay is advantageous
over traditional PIP-binding assays, including but not limited to low sample volume and no ligand/receptor labeling requirements, the ability to
test high- and low-affinity membrane interactions with both small and large molecules, and improved signal to noise ratio. Accordingly, the usage
of the PIP-on-a-chip approach will facilitate the elucidation of mechanisms of a wide range of membrane interactions. Furthermore, this method
could potentially be used in identifying therapeutics that modulate protein's capacity to interact with membranes.
Video Link
The video component of this article can be found at https://www.jove.com/video/55869/
Introduction
Myriad interactions and biochemical processes take place on two-dimensionally fluid membrane surfaces. Membrane-enclosed organelles in
eukaryotic cells are unique not only in biochemical processes and their associated proteome but also in their lipid composition. One exceptional
class of phospholipids is phosphoinositides (PIPs). Even though they comprise only 1% of the cellular lipidome, they play a crucial role in signal
transduction, autophagy, and membrane trafficking, among others1,2,3,4. Dynamic phosphorylation of the inositol head group by cellular PIP
kinases gives rise to seven PIP headgroups that are mono-, bis-, or tris-phosphorylated5. Additionally, PIPs define the subcellular identity of
membranes and serve as specialized membrane docking sites for proteins/enzymes containing one or more phosphoinositide-binding domains,
for example, Pleckstrin Homology (PH), Phox Homology (PX), and epsin N-terminal Homology (ENTH)6,7. One of the best-studied PIP-binding
domains is phospholipase C (PLC)-δ1 PH domain that specifically interacts with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) within a high
nanomolar-low micromolar range affinity8,9,10,11.
A variety of qualitative and quantitative in vitro methods have been developed and used to study the mechanism, thermodynamics, and
specificity of these interactions. Among the most commonly used PIP-binding assays are surface plasmon resonance (SPR), isothermal
calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, liposome flotation/sedimentation assay, and lipid-blots (Fat-blots/PIP-
strips)12,13. Even though these are extensively utilized, they all have many disadvantages. For example, SPR, ITC, and NMR require large
amounts of sample, expensive instrumentation, and/or trained personnel12,13. Some assay formats such as antibody-based lipid-blots utilize
water soluble forms of PIPs and present them in a nonphysiological manner12,14,15,16. In addition, lipid-blots cannot be quantitated reliably and
they have often resulted in false positive/negative observations12,17,18. To overcome these challenges and improve upon the current tool set, a
new label-free method was established based on a supported lipid bilayer (SLB) in the context of a microfluidic platform, which was successfully
applied to the study of protein-PIP interactions (Figure 1)19.
The strategy employed for detecting protein-PIP interactions is based on pH modulation sensing. This involves a pH-sensitive dye that has
ortho-Sulforhodamine B (oSRB) directly conjugated to phosphatidylethanolamine lipid head group20. The oSRB-POPE probe (Figure 2A) is
highly fluorescent at low pH and quenched at high pH with a pKa around 6.7 within 7.5 mol% PI(4,5)P2-containing SLBs (Figure 5B). PLC-δ1
PH domain has been used extensively for validating protein-PIP-binding methodologies due to its high specificity towards PI(4,5)P2 (Figure
5A)21,22,23,24,25.Hence, we reasoned that the PLC-δ1 PH domain can be used to test its binding to PI(4,5)P2 through the PIP-on-a-chip assay.
The PH domain construct used in this study has a net positive charge (pI 8.4), and thus attracts OH- ions (Figure 5C). Upon binding to PI(4,5)P2-
containing SLBs, the PH domain brings the OH- ions to the membrane surface, which in turn modulates the interfacial potential and shifts the
protonation state of oSRB-POPE (Figure 5C)26. As a function of the PH domain concentration, the fluorescence is quenched (Figure 6A).
Finally, the normalized data is fit to a binding isotherm to determine the affinity of the PH domain-PI(4,5)P2 interaction (Figure 6B, 6C).
In this study, a detailed protocol is provided to perform protein binding to PIP-containing SLBs within a microfluidic platform. This protocol takes
the reader from assembling the microfluidic device and vesicle preparation to SLB formation and protein binding. In addition, directions for data
analysis to extract affinity information for the PLC-δ1 PH domain-PI(4,5)P2 interaction are provided.
Protocol
1. Cleaning the Glass Coverslips
1. Dilute 7x Cleaning Solution (see Materials Table) 7-fold with deionized water in a 100 mm deep borosilicate glass dish with a flat bottom and
heat it up to 95 °C on a level hot plate for 20 min or until the cloudy solution becomes clear.
 
NOTE: The solution will be hot, use caution to avoid bodily injuries. The 7x Cleaning Solution is a proprietary blend of hexasodium [oxido-
[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate, 2-(2-butoxyethoxy)ethanol, sodium 1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-
sulfonate and non-hazardous additions.
2. Using tweezers, arrange the coverslips (40 mm length x 22 mm width x 0.16-0.19 mm height) on an aluminum staining rack in alternating
directions. Keep an empty spot between each coverslip to prevent them from touching each other.
3. Fully submerge the staining rack with the coverslips in the cleaning solution. Keep the coverslips in the solution for 1 h.
 
NOTE: As the water evaporates, keep adding fresh deionized water to keep the solution concentration unchanged.
4. Take the staining racks out of the cleaning solution and wash the coverslips with copious amounts of deionized water to remove the
detergent.
5. Dry the coverslips with nitrogen gas (approximately 5 min per staining rack), and then place the coverslips in a kiln for 6 h at 550 °C for
annealing.
 
NOTE: This is a crucial step that smoothens rough features on the glass surface.
6. Place the coverslips in a plastic container and keep them away from dust.
2. Fabricating Micropatterned PDMS Blocks
1. Mix polydimethylsiloxane (PDMS) prepolymer and the curing agent at 10:1 (w/w) ratio in a large plastic weigh boat and degas it in vacuum for
1 h with vacuum strength at 500 Torr or less.
 
NOTE: PDMS is a transparent and inert silicone polymer. To get the desired PDMS block thickness (0.5 cm), mix 55 g of the prepolymer with
5.5 g of the curing agent.
2. Place the silicon master which contains multiple replicates of the same SU-8 micropattern in a large (10 cm base diameter) plastic weigh boat
and pour in the degassed PDMS. Then, cure it in a dry oven at 60 °C overnight.
 
NOTE: Micropatterns are large enough to be seen with the naked eye. Each pattern contains 8 microchannels (100 µm width x 40 µm
height x 1 cm length) with 40 µm spacing in between (Figure 1A, 1B). Silicon wafer mold comprised of hard baked SU-8 photoresist was
fabricated in a nanofabrication facility27. Other approaches for master preparation include hydrofluoric acid (HF) etching, high-temperature
water etching, xurography, and 3D printing28,29,30,31. Commercial sources for silicon master preparation can also be used. The patterns for the
microfluidic device was designed with a drafting software (see table of materials). The original file containing the pattern design is provided as
a supplemental file "Pattern Design.dwg", which can be provided directly to the manufacturer.
3. Gently, peel off the PDMS from the silicon master with hands. Mark the boundaries of each micropattern in rectangles using a surgical scalpel
and a ruler. Then, cut the PDMS into blocks.
4. Punch 16 holes (8 inlets and 8 outlets per block) at both ends of each microchannel with a biopsy punch (1.0 mm hole diameter) as indicated
in Figure 3B.
5. Apply tape over each PDMS block to protect the micropatterns from damage and dust. Store them in a plastic container.
3. Preparing Small Unilamellar Vesicles (SUVs)
NOTE: Negative control bilayer composition is 99.5 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 0.5 mol%
ortho-Sulforhodamine B-1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (oSRB-POPE). Test bilayer composition is 92.0 mol% POPC,
0.5 mol% oSRB-POPE, and 7.5 mol% of either L-α-phosphatidylinositol-4-phosphate (PI4P) or L-α-phosphatidylinositol-4,5-bisphosphate
(PI(4,5)P2). Below is the procedure for preparing 92.0 mol% POPC, 0.5 mol% oSRB-POPE, and 7.5 mol% PI(4,5)P2-containing SUVs. The
synthesis of oSRB-POPE used in this study was previously described20.
1. Calculate the volume of POPC, PI(4,5)P2, and oSRB-POPE that needs to mixed, which accounts for the following total amounts: 2.22 mg of
POPC, 0.26 mg of PI(4,5)P2, and 2.1 x 10
-5 mg of oSRB-POPE.
2. Pipette the calculated volume of POPC, PI(4,5)P2, oSRB-POPE into a single 20 mL glass scintillation vial.
 
NOTE: POPC and oSRB-POPE stock solutions come in a chloroform solution, whereas the PI(4,5)P2 (and other phosphoinositides) stock
comes in a chloroform:methanol:water (20:9:1) solvent mixture. For accuracy, wet the pipette tip with chloroform before using it. For safety,
this step should take place inside a chemical fume hood.
3. Dry the mixture in a stream of nitrogen gas inside a chemical fume hood for 10 min or until the solvent evaporates and a thin lipid film forms
at the bottom of the vial.
4. Desiccate the mixture under vacuum for ≥3 h at a vacuum strength of 10 mTorr to remove any residual organic solvent.
 
NOTE: The 3 h desiccation time is sufficient for the scale of SUV preparation described in this protocol, which is adequate for 50
experiments. If a larger scale of SUV preparation is required, overnight desiccation can be performed.
5. Rehydrate the dried lipid film with 5 mL of running buffer (20 mM HEPES, 100 mM NaCl, at pH 7.0) and place it in an ultrasonic bath at an
operating frequency of 35 kHz for 30 min at RT.
 
NOTE: Mixing the amounts of lipids specified in step 3.1 and adding 5 mL of running buffer in step 3.5 yields a vesicle suspension at 0.5 mg/
mL. At this stage, the vesicle suspension is a mix of unilamellar and multilamellar vesicles (Figure 2B). The solution will appear pink/purple in
color and relatively turbid.
6. Freeze-thaw the vesicle suspension with liquid nitrogen and water bath at 40 °C to get unilamellar vesicles. Repeat the freeze-thaw 10 times.
 
NOTE: (Optional) To ensure the absence of non-unilamellar vesicles in the suspension, centrifugation step can be applied32,33.
7. Extrude the vesicle suspension through a 0.10 µm track-etched polycarbonate membrane using a lipid extruder (see table of materials) to
enrich for SUVs. Repeat the extrusion 10 times.
 
NOTE: A 15-mL conical tube can be used to collect the extruded vesicles. The solution should be void of turbidity at this stage. SUV diameter
can be confirmed via dynamic light scattering (DLS) (Figure 2C). SUVs are best suited for forming SLBs34.
8. Cover the conical tube with aluminum foil and store at 4 °C until ready to use.
4. Assembling the Microfluidic Device
1. Test the inlets and outlets of the PDMS block for blockage by squirting deionized water through the holes using a water wash bottle. Then, dry
the PDMS block with nitrogen gas.
 
NOTE: This step will also remove any dust particles that might have been trapped within and/or between channels. If necessary, dedust pre-
cleaned coverslips with nitrogen gas to remove any dust particles.
2. Place the PDMS block and the pre-cleaned coverslip (see section 1) inside the oxygen plasma system (see table of materials) sample
chamber to expose with oxygen plasma for 45 s with power setting at 75 Watts, oxygen flow speed at 10 cm3/min, and vacuum strength at
200 mTorr.
3. Place the patterned surface of the PDMS block in contact with the coverslip immediately after the oxygen plasma treatment. Press gently to
remove any air bubbles at contact sites.
4. Place the device on a level hot plate at 100 °C for 3 min to enhance the bonding.
5. Use a wet lint-free wipe (e.g. kimwipe) with 100% ethanol to remove any dust particles from the top (PDMS) and the bottom (glass) of the
device. Then, tape the device on top of a glass microscope slide.
 
NOTE: Do not use an excessive amount of ethanol and avoid ethanol getting into the inlet and outlet channels. Performing this step while the
device is still hot is recommended to ensure that the ethanol evaporates immediately. Glass microscopy slides can be stored in 100% ethanol
solution to remove dust and other contaminants.
5. Forming Supported Lipid Bilayers (SLBs)
1. Transfer 100 µL of PI(4,5)P2-containing SUVs from step 3.8 into a 0.65 mL microcentrifuge tube. Adjust the pH of the solution to ~3.2 by
adding 6.4 µL of 0.2 N hydrochloric acid.
 
NOTE: Confirm the pH of the solution with a pH meter equipped with a micro pH probe (see table of materials).
2. Pipette 10 µL of the pH-adjusted SUV solution into each channel through the inlet and apply pressure through the pipette until the solution
reaches the outlet. Detach the tip from the pipette and leave it attached to the device.
3. Repeat the above step for each channel and then incubate the device for 10 min at RT.
 
NOTE: Injection of vesicles into microchannels should be performed immediately after the device assembly.
4. Cut sets of inlet and outlet tubing each 60 cm (inlet tubing) and 8 cm (outlet tubing) long, respectively.
 
NOTE: Cutting the tubing diagonally and creating a sharp edge, makes it easier to insert the tubing into the inlets and outlets. The outlet
tubing should have an arc shape. The length of the inlet tubing may vary based on the microscope setup. The internal diameter of the tubing
is 0.05 cm.
5. Using tweezers, connect the outlet tubing set to the device, and then tape the device onto a microscope stage.
6. Submerge one end of the inlet tubing set in 25 mL of running buffer contained in a conical tube and tape it to make sure that the tubing is
secured.
7. Place the conical tube on a higher ground (~20 cm) than the device in order to push the solution through the microchannels via gravity flow; a
lab jack can be used to achieve this.
8. For each inlet tube, use a syringe to draw 1 mL of running buffer from the free end of the tubing. Remove the pipette tip from the inlet and
insert the free end of the inlet tubing into the device.
 
NOTE: Introduce a drop of running buffer onto the inlet to reduce the probability of an air bubble being introduced into the channel during this
step. After the inlet tubing is attached to the device, use a lint-free wipe to remove the excess buffer.
9. Repeat the above step to connect all the inlet tubing pieces to the device.
 
NOTE: Flowing running buffer through the channels helps to remove excess vesicles and equilibrate the bilayer to experimental conditions.
10. Open the microscope control software (see table of materials). On the left panel, click on the "Microscope" tab and choose the "10X"
objective.
11. Click on "Live" and then "Alexa 568" image icons on the toolbar. Using the fine and course adjustment knobs, focus on the microchannels.
12. Scan through the device to check the quality of the SLBs and the channels (Figure 8). Then, click "FL Shutter Closed" image icon on the
toolbar.
13. Click on the "Acquisition" tab, and under "Basic adjustments" select "Exposure time." Set the exposure time to "200 ms".
14. On the left panel, click on "Multidimensional Acquisition" and under the filters menu select the red channel (marked as "Alexa 568"). Then,
click on the "time lapse" menu, set the time interval to 5 min, duration to 30 min, and click "Start".
 
NOTE: Based on the duration (30 min) and the flow rate (~1.0 µL/min), 30 µL of running buffer is used to equilibrate the SLB within a channel,
i.e. 240 µL of running buffer is used for all 8 channels.
15. Select the "Circle" tool under the "Measure" tab and draw a circle in any channel. Right click while the circle is selected and
choose "Properties". Under the "Profile" tab, check "all T" to view the fluorescence intensity as a function of time.
1. Make sure this curve reaches a plateau, which indicates equilibrium, before proceeding to the next step.
16. Lower the buffer solution to an equal ground as the device to stop the flow.
17. Save the time lapse file.
6. Testing PLC-δ1 PH domain interaction with PI(4,5)P2-containing SLBs
1. Prepare dilutions of the PH domain using the running buffer as a diluent.
 
NOTE: Since there are eight channels within the device, use at least two of them for blank controls. Pick the far ends on each side and
use the remaining channels for protein dilutions. The following PH domain concentrations were tested: 0.10, 0.25, 0.50, 1.00, and 2.50 µM.
Approximately 200 µL of each dilution was sufficient to reach equilibrium within 30 min.
2. One at a time, detach each outlet tubing and apply 200 µL of each protein dilution into the outlet channel using a pipette. Do not apply any
pressure, let gravity do the work. Detach the tip from the pipette and leave it attached to the microfluidic device.
3. Repeat the above step for each channel and make sure that air bubbles are not introduced into the channels during this process.
4. Lower the inlet tubing to a ground below the microfluidic device to start flowing the protein through the microchannels. Tape the free end of
the tubing to a waste container. Flow the protein dilutions for 30 min.
 
NOTE: This will reverse the flow and allow the protein to be introduced into the channels. The time to equilibration and volume of protein
dilutions needed will be dependent on the affinity of the interaction.
5. On the left panel of the software, under the "Time Lapse" tab, click on "Start" to begin imaging again.
6. Repeat the step 5.15 to make sure equilibrium is reached. When the experiment is complete, save the time lapse file.
7. Assessing Membrane Fluidity
NOTE: Fluorescence Recover After Photobleaching (FRAP) experiments should be performed with each new batch of SUVs and cleaned glass
coverslips to ensure that the SLBs are fluid.
1. Follow the procedure for cleaning glass coverslips (1.1-1.6), fabricating micropatterned PDMS blocks (2.1-2.5), preparing SUVs (3.1-3.8),
assembling the microfluidic device (4.1-4.5) and forming SLBs (5.1-5.17) as previously described.
2. Focus the microscope on the bilayer, set the exposure time to 200 ms, and the binning to 1.
3. Photo-bleach a circular spot using a 532 nm, 2 mW laser beam (13 µM radius). Immediately after photobleaching, start capturing a series of
images every 3 s for the first 45 s, followed by a 30 s interval for the remainder of the time (15 min total duration). Once the data acquisition is
complete, save the time lapse file.
4. Select the bleached area using the circle drawing tool to extract fluorescence intensity values as a function of time. Additionally, select two
more areas nearby, one corresponding to an unbleached region and one corresponding to a region without any SLBs.
5. Calculate the fluorescence recovery (y) using the following equation:
 
 
NOTE: Here Ft represents the intensity of the bleached region as a function of time, Fi represents the fluorescence intensity before bleaching
(use "1" as a normalized value in this case); F0 is the background intensity.




NOTE: Here A represents the mobile fraction and k is the kinetic constant for the mobile fraction, which is used to calculate the half-time to
recovery (t1/2):
 
7. Use the t1/2 to calculate the diffusion constant (D):
 
 
NOTE: Here R represents the laser beam radius (13 µm). The diffusion constant for a fluid bilayer should be ≥1.0 µm2/s.
8. Processing Data
NOTE: The routine of the data analysis will be dependent on the microscope, image processing software, and the curve-fitting software being
used.
1. Open the time lapse files of before (from step 5.17) and after (from step 6.6) titrating the PH domain. Go to the last frame of each time lapse
file and do a line scan across all the microchannels to obtain the fluorescence intensity data as a function of distance in pixels (Figure 6A).
Transfer the data to a spreadsheet software.
2. For each microchannel (before and after PH domain addition), sample some data within the channel and either side of the channel
representing the baseline (Figure 7A).
 
NOTE: The blank channel fluorescence intensity should have remained unchanged. All the other channels are normalized to the blank
channel, so it is crucial to have two blank channels and make sure that their fluorescence intensities remain consistent with each other.
3. Apply the formula below to normalize the data to the blank channel; a sample calculation is provided in Figure 7B.
 
 
NOTE: Here ΔFprotein represents the background subtracted fluorescence intensity of the protein channel, ΔFblank represents the background
subtracted fluorescence intensity of the blank channel, pre and post refer to before and after protein titration steps, and α represents the
correction factor which is the ratio of the fluorescence intensities of the protein channel and the blank channel ([Fprotein/Fblank]pre) at a pre-
protein titration step. Since the fluorescence intensity decreases as a function of the PH domain concentration, normalized data will be
negative in value.
4. Using a curve-fitting software (see Materials Table), plot the normalized fluorescence as a function of PH domain concentration and fit to a
Langmuir isotherm (Figure 6C):
 
 
NOTE: Here ∆F represents the change in fluorescence intensity relative to the maximum change in fluorescence intensity when a saturation
concentration of protein is present (∆Fmax), whereas the Kd,app represents the apparent dissociation constant, which is equal to the bulk
protein concentration ([PLC-δ1 PH]) at which 50% coverage (membrane bound complex) is achieved. This is an equilibrium-based binding
measurement so the normalized data is fit to a simple Langmuir isotherm to extract an apparent experimental parameter Kd,app. Based on the
fitting software the Kd,app for PLC-δ1 PH-PI(4,5)P2 interaction is 0.39 ± 0.05 µM (Figure 6B).
Representative Results
We used the pH modulation assay to study the PLC-δ1 PH domain-PI(4,5)P2 interaction within a PIP-on-a-chip microdevice (Figure 1). Through
a detailed protocol, we demonstrated how to prepare and assemble microfluidic device components, make small unilamellar vesicles (SUVs)
(Figure 2), form SLBs within a device (Figure 3), and tested protein binding to PIP-containing SLBs. A flowchart of a typical SLB binding
experiment is depicted in Figure 4. The principle of the pH modulation assay is illustrated in Figure 5 using the PH domain-PI(4,5)P2 binding as
an example. Results obtained from this study suggested that the PH domain binds to PI(4,5)P2-containing SLBs. More specifically, we observed
that upon binding, the local pH became more basic. This local pH change was sensed by the oSRB-POPE fluorescent probe present within
SLBs, which was then quenched accordingly (Figure 6A, 6C). The quenching was concentration dependent and saturable, so fitting the data to
a Langmuir isotherm yielded a Kd,app of 0.39 ± 0.05 µM (Figure 6B, 6D). The PH domain showed selectivity towards PI(4,5)P2 since no binding
was observed towards POPC (zwitterionic lipid), and weaker binding towards PI4P-containing SLBs (Kd,app = 1.02 ± 0.20 µM) (Figure 6B). A
sample calculation is included to show how fluorescence data is processed (Figure 7). In Figure 8, series of microchannel images are presented
to provide visual clues in determining the quality of SLBs and the microchannels.
 
Figure 1: PIP-on-a-chip microfluidic device for studying protein-PIP interactions. (A) The microfluidic device has 8 microchannels with
8 inlets and 8 outlets. Colored solutions were flowed through to make the channels visible in this image. The device is 2.0 cm in width (x),
0.5 cm in height (y), and 3.0 cm in length (z). (B) The floor of the microchannels is glass, whereas the walls and ceilings are made up of
polydimethylsiloxane (PDMS). Each microchannel is 100 µm in width, 40 µm in height, and 1 cm in length. The spacing between two adjacent
microchannels is 40 µm. Supported lipid bilayers (SLBs) are formed on top of the glass surface. Please click here to view a larger version of this
figure.
 
Figure 2. Small unilamellar vesicle (SUV) preparation and quality control studies. (A) Lipid components used in the making of vesicles:
ortho-Sulforhodamine B-POPE (oSRB-POPE), L-α-phosphatidylinositol-4-phosphate (PI4P), L-α-phosphatidylinositol-4,5-bisphosphate
(PI(4,5)P2), and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC). (B) Types of lipid vesicles: SUV, large unilamellar vesicle (LUV), giant
unilamellar vesicle (GUV), and multilamellar vesicle (MLV). SUVs are best suited for preparation of SLBs34. (C) Dynamic light scattering (DLS)
based confirmation on the size of the vesicles post-lipid extrusion (through 0.1 µm filter). Hydrodynamic radius (Rh) of 53.9 nm confirms that the
mean of the vesicle size distribution is ~100 nm. Results represent the measurement from PI(4,5)P2-containing SUVs. Please click here to view a
larger version of this figure.
 
Figure 3: SLB formation on a glass support. (A) Vesicles of desired lipid composition are prepared and then flowed through microchannels.
Vesicles are adsorbed to the glass surface and deformed. Once a critical surface coverage is achieved, vesicles rupture spontaneously to form
SLBs. Adapted from references35,36. (B) SLBs within a device under a 10X objective is shown. Alexa 568 filter set (excitation/emission at 576/603
nm) is used. Please click here to view a larger version of this figure.
 
Figure 4: Flowchart of a typical SLB binding experiment. Microfluidic device components i.e. patterned PDMS block and cleaned coverslips,
are treated with oxygen plasma to make both surfaces hydrophilic and then assembled. SUVs are flowed through microchannels to form
SLBs. Excess vesicles are removed and SLBs are equilibrated to experimental conditions by flowing a running buffer solution. Then, protein
dilutions are flowed through microchannels. Finally, the fluorescence intensity data is analyzed, normalized, and plotted as a function of protein
concentration. The normalized data is fit to a function to extract an apparent dissociation constant (Kd,app) value. Please click here to view a
larger version of this figure.
 
Figure 5: Principles of the pH modulation-based sensing. (A) X-ray crystal structure of the PLC-δ1 PH domain in complex with PI(4,5)P2
head group inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (PDB ID: 1MAI)
37. (B) The oSRB-POPE probe is highly fluorescent at low pH and
quenched at high pH with a pKa of 6.7 within 7.5 mol% PI(4,5)P2-containing SLBs as indicated in the pH titration curve. (C) The PH domain
used in this study has an isoelectric point (pI) of 8.4, so at experimental pH (7.0) the protein is positively charged. Bearing a net positive charge,
the protein attracts OH- ions. When the PH domain binds to PI(4,5)P2-containing SLBs, it brings the OH
- ions to the membrane surface, the
interfacial potential is modulated which in turn shifts the protonation state of oSRB-POPE, and its fluorescence is quenched in PH domain
concentration-dependent manner. Please click here to view a larger version of this figure.
 
Figure 6: PLC-δ1 PH-membrane binding monitored via pH modulation. (A) The view of the microchannels before and after adding the PH
domain at indicated concentrations. (B) Comparison of the affinities toward POPC, PI4P, and PI(4,5)P2-containing SLBs. PH domain binding to
7.5 mol% PI(4,5)P2-containing SLBs yielded a Kd,app of 0.39 ± 0.05 µM. Weaker binding was observed towards 7.5 mol% PI4P-containing SLBs
(Kd,app of 1.02 ± 0.20 µM) and no binding was observed for pure POPC SLBs. Error bars indicate SEM (n = 3). Two-tailed t-test was used to
compare the affinities between PI4P and PI(4,5)P2 binding (*p = 0.0396). (C) Fluorescence intensities from the line scan across microchannels
are plotted as a function of distance in pixels for POPC, PI4P, and PI(4,5)P2 binding experiments. (D) Normalized and averaged POPC, PI4P,
and PI(4,5)P2 binding data is plotted as a function of PLC-δ1 PH domain concentration and then fit to a Langmuir isotherm to extract Kd,app. See
the equation in step 8.4 for details. Please click here to view a larger version of this figure.
 
Figure 7: Sample calculation for data processing. (A) Before (black) and after (red) protein titration line scan data for blank (no protein)
and protein channel, where fluorescence intensity data is presented as a function of distance in pixels. Shaded areas represent the regions
that were used to extract data for the calculations. Baseline fluorescence intensity data is extracted right before and after each channel. (B)
Data is extracted for blank and protein channels, both before and after protein titration. Averages are taken for baseline and within a channel
fluorescence data. After baseline subtraction, the fluorescence data is normalized to the blank channel. See the equation in step 8.3 for details.
Please click here to view a larger version of this figure.
 
Figure 8: Assessing the integrity of SLBs and microchannels. (A) An image illustrating high-quality SLBs and microchannels. (B) Incomplete
fusion. (C) Fused microchannels. (D) Dust particle trapped within a microchannel. (E) Air bubbles trapped within microchannels. Please click
here to view a larger version of this figure.
Supplemental File 1: Pattern_Design.dwg Please click here to download file.
Discussion
Each PIP variant, albeit at low concentrations, is present on the cytosolic surface of specific organelles where they contribute to the
establishment of a unique physical composition and functional specificity of the organellar membrane1. One of the most important uses of PIPs
is as a specific docking platform for the multitude of proteins requiring specific subcellular localization and/or activation6,7. Due to their role in
cellular physiology and disease, the ability to study protein-PIP interactions in vitro, in a physiologically relevant context is important. The assay
format described herein allows one to consider protein-PIP interactions in the context of a fluid lipid bilayer, in the presence of a mixture of
phospholipids, with the normal presentation of the polar head group, and natural-length fatty acyl chains.
This assay, in combination with pH modulation as its detection system, and SLBs as a model membrane system set in a microfluidic platform,
provides unique advantages compared to other membrane binding techniques. First of all, the microfluidic platform saves on materials due to the
low volume requirements both for protein and lipids used (40 nL overall channel volume; 1.0 mm2 SLB surface area). In addition, physiologically
relevant lipid compositions can be used, while still maintaining two-dimensional membrane fluidity (≥1.0 µm2/s)28,38. The detection system
provides improved signal to noise ratio compared to ITC, SPR, and quartz crystal microbalance with dissipation (QCM-D) monitoring, which
allows one to test not only protein-membrane interactions but ion,small molecule, peptide-membrane interactions as well19,20,39,40. Also, the
pH sensitive fluorescent probe is highly stable and does not photobleach under the experimental conditions tested19,20,41. Another advantage
of this platform is the ability to observe the membrane surfaces visually. Certain interactions may induce lipid microdomain formation and/or
affect membrane fluidity, which can be visualized directly and/or tested via fluorescence recovery after photobleaching (FRAP), respectively42.
The assay described here does not require any expensive instrumentation beyond a fluorescence microscope. Finally, and most importantly,
assessing membrane interactions in the absence of ligand/receptor labeling makes the PIP-on-a-chip assay the preferred method over the
traditional ones.
Although the PIP-on-a-chip assay is a powerful technique, peripheral membrane proteins can differ in the overall composition of cationic and
anionic residues and their distribution within/around the binding site, which create certain challenges. Some proteins have PIP-binding sites
composed of many basic residues, whereas others have only a few. Therefore, the H+/OH- ratio at the binding site is going to be different, and so
is the magnitude of the change in the local pH upon binding. The stoichiometry of the interaction and whether or not the PIP-binding is stabilized
by interactions with other lipids further complicates the case. Accordingly, the pI of a protein, especially for a large protein, may not be the only
indicator of the expected fluorescence change. While some protein-PIP interactions will result in large fluorescence changes, the rest may result
in small fluorescence changes. In the latter case, at least two actions can be taken to enhance the signal to noise ratio: 1) using larger PIP levels
on the bilayer to increase the number of proteins recruited to the surface, i.e. increasing the number of recruited OH- ions and the number of
quenched oSRB-POPE molecules; 2) increasing the oSRB-POPE levels to enhance the signal to noise ratio.
Even though the current platform provides many advantages for studying peripheral membrane proteins, it has some challenges for the
study of transmembrane proteins. Due to the SLB-glass support proximity (water layer is about 1-2 nm depending on the lipid composition),
transmembrane protein-glass support interaction can promote protein denaturation, lead to loss of function, and immobilization34,43,44,45. Even
though more involved, a variety of approaches have been developed to overcome these challenges, such as surface modification of the glass
support to provide polymer cushion or including lipopolymer tethers (for example PEGylated lipids) within the bilayer to increase the SLB-glass
support distance34,46,47,48.
Forming high-quality SLBs is the most critical aspect of the PIP-on-a-chip assay (Figure 8A). Using clean coverslips and fresh SUVs is
recommended to assure reproducibility. Due to the presence of anionic lipids, such as PI(4,5)P2, SUVs are negatively charged, which lowers the
SUV rupturing efficiency and affect the membrane fluidity (Figure 8B). Therefore, pH adjustment of the SUV solution is crucial to protonate the
PI(4,5)P2 head group phosphates and decrease the electrostatic repulsion with the glass to increase the rupturing efficiency
49,50. SUVs that do
not contain anionic lipids, do not require any pH adjustment. In addition, SUVs should be injected into channels right after the oxygen plasma
treatment and bonding, while the glass coverslip surface is still hydrophilic, which is required for SLB formation. Besides the SLB quality, dust
particles represent another issue. During the device fabrication process, a dust particle trapped between channels can cause channel fusion,
whereas a dust particle trapped within a channel can damage the SLB and/or reduce the solution flow speed (Figure 8C, 8D). The work area
should be cleaned periodically to remove dust. Similarly, exposure of an air bubble into a channel should be avoided at any step, which otherwise
will damage the SLB irreversibly (Figure 8E).
Another parameter to consider when planning a PIP-on-a-chip assay is the protein storage buffer. If used at high concentrations, individual
components (stabilizing agents, reducing agents, salts, antimicrobial agents, chelating reagents, etc.) may affect the fluorescence and/or SLB
integrity. Therefore, the storage buffer should be titrated to test its effect. If an effect is observed, the SLBs should also be equilibrated to the
storage buffer conditions before titrating the protein to prevent a drift in fluorescence. Considering that this is a pH modulation based assay, if
possible, the purified protein should also contain the same buffering component as the running buffer (in this case 20 mM HEPES at pH 7.0) to
minimize the drift in fluorescence caused by the buffer mismatch.
In conclusion, we have demonstrated that the pH modulation assay can be used successfully to investigate protein-PIP interactions. Even
though the emphasis was on PIPs, this platform can be used to test interactions with more complex membrane systems that include other
physiologically relevant lipids such as phosphatidylserine, phosphatidylethanolamine, phosphatidic acid, and cholesterol, among others28,39,42,51.
Beyond cellular proteins, this assay platform can also be beneficial for those studying human pathogens. For example, proteins encoded by
viruses and bacteria have been shown to interact with cellular membranes and some specifically with PIPs52,53,54,55,56. Accordingly, PIP-on-a-chip
assay can provide a means to discover and characterize small-molecule inhibitors of protein-PIP interactions.
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